| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 135.97B | 130.92B | 137.12B | 132.88B | 136.03B | 124.31B |
| Gross Profit | 43.05B | 39.88B | 43.18B | 41.72B | 40.48B | 37.61B |
| EBITDA | 12.09B | 12.19B | 16.04B | 10.92B | 12.53B | 11.90B |
| Net Income | 3.21B | 510.00M | 6.28B | 5.11B | 4.50B | 2.94B |
Balance Sheet | ||||||
| Total Assets | 158.63B | 153.61B | 159.68B | 161.97B | 165.93B | 158.22B |
| Cash, Cash Equivalents and Short-Term Investments | 10.02B | 9.94B | 10.54B | 10.82B | 11.55B | 14.47B |
| Total Debt | 15.81B | 13.85B | 8.86B | 9.21B | 16.09B | 10.68B |
| Total Liabilities | 46.63B | 39.86B | 38.69B | 41.51B | 48.24B | 43.43B |
| Stockholders Equity | 110.24B | 111.85B | 119.19B | 118.77B | 115.88B | 113.03B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.87B | 1.06B | 2.79B | -9.02B | 3.80B |
| Operating Cash Flow | 0.00 | 17.27B | 11.57B | 10.41B | 1.79B | 9.15B |
| Investing Cash Flow | 0.00 | -11.59B | -7.49B | -190.00M | -5.92B | 6.81B |
| Financing Cash Flow | 0.00 | -6.32B | -5.18B | -11.35B | 1.01B | -12.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥175.17B | 15.00 | 10.24% | 2.43% | 7.59% | 9.69% | |
77 Outperform | ¥146.53B | 22.38 | ― | 1.79% | 7.03% | 26.11% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥1.67T | 10.41 | 3.37% | 1.85% | 0.85% | 8.37% | |
59 Neutral | ¥239.11B | 15.12 | 5.31% | 2.29% | -1.37% | 104.77% | |
54 Neutral | ¥108.47B | -36.94 | 2.80% | 3.38% | -4.52% | -91.68% | |
46 Neutral | ¥16.35B | -8.56 | ― | ― | -1.88% | -202.60% |